Fig. 1From: Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung diseasePlasma CXCL4 levels (ng/ml) were significantly higher in SSc-ILD patients (N = 136) compared with healthy controls matched for age, gender, and ethnicity (N = 67), P = 0.019. SSc systemic sclerosisBack to article page